The Motley Fool

3 FTSE 100 dividend shares still paying out that I’m buying

Image source: Getty Images

The coronavirus market crash means more than a third of FTSE 100 dividend shares have reversed course and cut payouts to shareholders. UK investors will lose out on more than £20bn in expected dividend payments as a result.

But there are still some top quality FTSE 100 dividend shares bucking this trend.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

The three I’ll cover today are 3i Group (LSE:III), Legal & General (LSE:LGEN) and British American Tobacco (LSE:BATS).

These three shares are between 15% and 32% cheaper than at the start of 2020. But follow the charts and you’ll see each is in a general uptrend since the devastating lows of 19 March.

Legal & General

Short sellers have tried to push down the LGEN price in recent weeks, but it keeps bouncing back. The share price dropped 10% in a week when doom-mongers placed big bets it would follow Lloyds, Barclays and RBS and cancel its 2020 full-year dividend.

But the naysayers got their fingers badly burned when CEO Nigel Wilson confirmed he would pay a 12.64p final dividend. This £753m loyalty bonus confirms to me that the balance sheet is strong enough to see the company through this short-term weakness.

I can hardly believe my luck that I can pick up Legal & General on a P/E ratio of 6, with a confirmed 8.5% dividend yield. Tens of thousands of private investors rely on their dividends for income. And younger investors might buy to reinvest dividends, using the magic of compounding to produce greater Stocks and Shares ISA wealth.

3i Group

I’ve long been a fan of this FTSE 100 investment firm because of its geographical and sector diversity. And paying a 4.5% dividend is just the beginning. Managers Ben Loomes and Phil White have their finger on the pulse of quality investments and two in particular stand out recently.

One is £214m for a large data centre provider and the other is £60m to create a bioprocessing platform to speed up commercial production of vaccines. The global lockdown has seen home internet and video usage skyrocket. Meanwhile biopharma companies now need to ramp up test and vaccine research and production, so these investments look like very good decisions indeed.

In the last 12 months, the net asset value (NAV) has grown by 13%. And you can buy at a 15% discount to NAV right now. If you had bought at any other time in the last 12 months you would have paid an average 29% premium. So I see plenty of long-term upside just waiting for investors to cash in.

British American Tobacco

I covered British American Tobacco in March when broker Jeffries said buying this FTSE 100 dividend share was “practically stealing. And my mind hasn’t changed.

There’s no indication CEO Jack Bowles plans to cut the 7.1% yield. Analysts at Citi added in a recent research note that BATS would be able to pay off interest, debts and still maintain dividend payouts in 2020.

Some investors might give BATS a swerve because of the ethics of investing in tobacco, as well as a lower share price compared to just a few years ago. But on a purely financial level based on the price today, it makes sense. I expect both share price appreciation and dividend growth going forward, simply because the company generates so much cash. 

At prices 15% cheaper than January I’m grabbing as much in my ISA as I can afford.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Tom Rodgers owns shares in Legal & General. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.